Further validation through subcutaneous xenograft models, Magi3-knockout mice, and clinical analyses underscored the crucial involvement of the MAGI3/MAS/ERK axis in RCC development (Fig. 6, Supplementary Figs. 2, 3). This evidence concerns the gene MAGI3 and renal cell carcinoma.